Suki AI vs CoverMyMeds
Side-by-side comparison of AI visibility scores, market position, and capabilities
Redwood City ambient voice AI for physicians converting patient conversations into EHR-coded SOAP notes and diagnoses; integrates with major EHR systems to reduce documentation time.
About
Suki AI is a Redwood City-based clinical AI company that provides physicians with an ambient voice assistant that listens to patient-physician conversations during appointments and automatically generates structured clinical notes in the EHR, dramatically reducing the documentation burden that contributes to physician burnout. Suki's AI processes natural conversation audio to extract clinically relevant information, populate SOAP notes, and code diagnoses and procedures — turning a 15-minute documentation task into a 2-minute review and sign-off. The platform integrates with major EHR systems including Epic, Cerner, and Athena and is designed to fit naturally into clinical workflows without requiring physicians to change how they see patients. Suki serves health systems, physician groups, and telehealth companies looking to improve clinician efficiency and satisfaction. Founded in 2017 by former Google and Flipkart executives, Suki raised over $165M from investors including Venrock, First Round Capital, and Flare Capital Partners. It competes with Nuance DAX, Abridge, and DeepScribe in the ambient AI documentation market.
Largest prior authorization network in the US connecting 75K+ pharmacies, 750K+ providers, and all payers. Columbus OH; acquired by McKesson; available free to providers and pharmacies; processes millions of PA requests annually for specialty and retail prescriptions at no provider cost.
About
CoverMyMeds is the largest prior authorization platform in the United States, operating a network that connects more than 750,000 providers, 75,000 pharmacies, and virtually all payers to streamline the authorization process for prescription medications. Founded in 2008 in Columbus, Ohio, and acquired by McKesson Corporation in 2017, CoverMyMeds processes millions of prior authorization requests annually and has become foundational infrastructure for the US pharmacy and specialty medication market. The platform is available at no cost to providers and pharmacies and is funded through health plan and PBM partnerships.\n\nCoverMyMeds' network effect is central to its value: because the platform is used by the vast majority of pharmacies and a very large share of prescribing providers, payers can reach their entire provider and pharmacy network through a single connection. The platform supports real-time benefit checks that show the formulary status and prior authorization requirements for a drug at the point of prescribing, enabling providers to make more informed prescribing decisions before a patient reaches the pharmacy counter. Automated electronic prior authorization (ePA) workflows reduce approval times from days to hours for eligible drug-payer combinations.\n\nAs part of McKesson, CoverMyMeds has expanded its capabilities to include specialty medication access solutions, patient assistance program enrollment, and medication adherence tools. The company's RxCrossroads subsidiary provides hub services for specialty pharmaceutical manufacturers, creating a comprehensive access ecosystem that spans from initial authorization through patient support and adherence management.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.